The relationship between serum homocysteine levels and development of coronary collateral circulation in patients with acute coronary syndrome

Abstract

Aim: Homocysteine is an amino acid that plays a role in folate metabolism and inhibits endothelial cell proliferation which is important for angiogenesis. In this study, we aimed to investigate the relationship between serum homocysteine levels and coronary collateral development.

Material and Method: 176 consecutive patients, with acute coronary syndrome and chronic total occlusion, were divided into two groups according to coronary collateral development. Rentrop 0 and 1 were regarded as group I and Rentrop 2 and 3 as group II.

Results: Plasma homocysteine levels were 18,2 ± 7,0 μmol/L in the group I and 15,7 ± 5,1 μmol/L in the group II. Univariate logistic regression analysis showed that mean platelet volume and homocysteine were associated with poor coronary collateral. Multivariate logistic regression analysis showed that homocysteine level was independently associated with poor coronary collateral circulation (OR 1,069 [95% CI 1,012-1,130]; P=0,018).

Conclusion: In this study clearly demonstrates that high serum homocysteine level is associated with poor collateral development in patients with acute coronary syndrome.

Keywords

• Coronary artery disease,coronary collateral circulation,homocysteine

Akut koroner sendromlu hastalarda serum homosistein düzeyleri ile koroner kollateral dolaşım gelişimi arasındaki ilişki

Abstract

Amaç: Homosistein, folat metabolizmasında rol oynayan, anjiyogenez için önemli olan endotelyal hücre proliferasyonunu inhibe eden bir aminoasittir. Bu çalışmada serum homosistein düzeyiyle koroner kollateral gelişimi arasındaki ilişkiyi araştırmayı amaçladık.

Gereç ve Yöntem: 176 kronik total oklüzyonu olan hasta koroner kollateral gelişimine göre 2 gruba ayrıldı. Rentrop 0 and 1 olanlar grup I Rentrop 2 ve 3 olanlar grup II olarak kabul edildi.

Sonuç: Plazma homosistein düzeyleri grup I'de 18,2 ± 7,0 μmol / L ve grup II'de 15,7 ± 5,1 μmol / L olarak saptandı. Tek değişkenli lojistik regresyon analizi ortalama trombosit hacmi ve homosisteinin zayıf koroner kollateral ile ilişkili olduğunu gösterdi. Çok değişkenli lojistik regresyon analizi homosistein düzeyinin bağımsız olarak zayıf koroner kollateral dolaşım ile ilişkili olduğunu göstermiştir  (OR 1,069 [% 95 CI 1,012-1,130];P=0,018).

Keywords

• Koroner arter hastalığı,koroner kollateral dolaşım,homosistein

References

1. 1. Cohen MV. The functional value of coronary collaterals in myocardial ischemia and therapeutic approach to enhance collateral flow. Am Heart J 1978;95:396-404.
2. 2. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74:469–76.
3. 3. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation. 2007;116:975–83.
4. 4. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, et al. Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol.2009;132:257–62.
5. 5. Seiler C. The human coronary collateral circulation. Eur J Clin Invest 2010;40:465–76.
6. 6. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38:1872–8.
7. 7. Fowler B. Homocysteine an independent risk factor for cardiovascular and thrombotic diseases. Ther Umsch 2005;62:641-6.
8. 8. Nagai Y, Tasaki H, Takatsu H, Nihei S, Yamashita K, Toyokawa T, et al. Homocysteine inhibits angiogenesis in vivo and in vitro. Biochem Biophys Res Commun 2001; 281: 726– 731.

9. 9. Rentrop Kp, Cohen M, Blanke H, Philips RA. Changes in collateral filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587– 592.